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Background. Geographic isolation, poverty, and loss of culture/tradition contribute to “epidemic” rates of diabetes amongst
indigenous Canadians. The Mobile Diabetes Screening Initiative travels to rural indigenous and other remote communities in
Alberta to screen for diabetes and cardiovascular risk. We sought to examine risk factors longitudinally. Methods. Clinical and
anthropometric measurements were undertaken for 809 adults (aged 20–91) between November 2003 and December 2009.
For those who had more than one MDSi visit, trend estimates (actual changes) were calculated for body mass index (BMI),
weight, waist circumference, hemoglobin A1c (A1c), total cholesterol, and blood pressure. Results. Among those without diabetes
(N = 629), BMI and weight increased (P<. 01) and blood pressure decreased (P<. 05). For those with diabetes (N = 180),
signiﬁcant improvements (P<. 05) were observed for all indicators except waist circumference. Conclusion. Improvements
observed suggest that MDSi’s model may eﬀectively mediate some barriers and support subjects in managing their health.
1.Introduction
In 2006-2007, approximately two million Canadians (6% of
the country’s population) had diagnosed diabetes [1]. This
rate is projected to increase to 2.6million by 2011, represent-
ing a 33% increase from 2006 [2, 3].
The International Diabetes Federation (IDF) estimates
about half of diabetes cases remain undiagnosed and, there-
fore, estimated Canada’s national prevalence for people aged
20–91tobe9%for2007,and12%for2010[4].Canadaranks
among the world’s industrialized countries with the highest
rates of type 2 diabetes. Add to this an impaired glucose
tolerance (IGT) prevalence estimated at 13% for Canada for
2010 [4]. Diabetes-related costs consumed an estimated 13%
of total health care spending in Canada in 2010 [4].
Increases in prevalence are expected to continue as
Canada’s demographic proﬁle shifts with the aging popu-
lation, increased immigration from high-risk populations,
and a growing indigenous population [5]. Age-adjusted
prevalence rates have been estimated to be 3.6 times higher
for First Nations indigenous men and 5.3 times higher for
First Nations indigenous women compared to the general
Canadian population [6].
In addition to First Nations people, Canada recognizes
two other indigenous groups: the Inuit, inhabitants of the
far North, and the M´ etis, who are children of relationships
between Europeans and the indigenous population prior to
and throughout the colonial settlement of Canada. These
relationships established political alliances and provided the
colonial regimes with local expertise regarding subsistence
and harvesting natural resources [7]. The M´ etis are distinct
from First Nations populations in terms of culture, history,
and sociopolitical and socioeconomic factors.
Little is known about diabetes prevalence among the
Inuit or the M´ etis people in Canada though in the 2001
Aboriginal Peoples Survey (APS), 6% of M´ etis respondents
reported having diabetes [8]. In Alberta self-reported preva-
lence of diabetes was 6% in 2006, with a crude diabetes
prevalence increase of 66% between 1998 and 2006 [9].2 International Journal of Family Medicine
Located in Western Canada, the province of Alberta
stretches 1,223 kilometres from north to south, 660 kilo-
meters east to west (661,848 square kilometers). Much of
northern Alberta is isolated, covered by boreal forest, with a
subarctic climate. Adequate road access is an issue for many
rural communities, especially those in the north.
Alberta has an ethnically diverse population of 3.7
million people (2009), of which about 6% self-identiﬁes as
indigenous (of M´ etis, First Nations, or Inuit heritage) [10].
Eighty-one percent of the province’s total population resides
inmetropolitan and urbanareas; 19%livein ruralareas[11].
In 2009, 63% of Alberta’s indigenous population resided in
urban areas [12].
In 2009, 85,500 M´ etis people lived in Alberta. Eighty-
eight percent resided in major urban centres, while 7,990
(approximately 10%) were members of eight incorporated
M´ etis settlements which have unique terms of governmental
jurisdiction for service delivery [12, 13].
In 2009, there were 105,301 First Nations people residing
in Alberta, of whom 36% lived oﬀ reserve [12].
The province’s three major metropolitan centres are
located in central and southern Alberta; in northern Alberta,
there are two major urban centres—Grande Prairie, popula-
tion 50,227; Fort McMurray, population 63,676—and only
two towns (Slave Lake and Peace River) with populations
over 5,000 [10]. Many northern residents ﬁnd employment
at industry sites centralized in the north, such as the Atha-
basca Oil Sands.
Generalists (general practitioners and family doctors)
provide the majority of medical care for Albertans with
diabetes, with rural residents having lower rates of specialist
care visits compared to metropolitan residents [2]. The
increase in diabetes prevalence has meant increased demand
for health care resources, particularly to address comorbid
conditions and the complications of diabetes [2]. Findings
in the 2009 Alberta Diabetes Atlas make clear the need for
enhancing primary prevention and management, such as
ensuring adequate numbers of generalist practitioners and
allied health professionals (nurses, dietitians, and pharma-
cists). Additionally, culturally appropriate prevention and
management initiatives should be prioritized for indigenous
people and communities [2].
In 2003, Alberta initiated a 10-year diabetes strategy,
t h r o u g hw h i c ht h ep r o v i n c eh a sf u n d e dt h eM o b i l eD i a -
betes Screening Initiative (MDSi). MDSi operates out of
the University of Alberta in Edmonton and is a collab-
orative eﬀort between university researchers, community
stakeholders, Alberta Health and Wellness, northern zone
service providers, and policy/decision-maker stakeholders.
MDSi travels to 25 M´ etis, oﬀ-reserve First Nations com-
munities and other remote, rural communities in northern
Alberta. The program provides screening services for dia-
betes, diabetes risk, and cardiovascular risk in community
settings. (Most First Nations people in rural Alberta live
on reserves, which are federal in primary health care
jurisdiction, and as such, a similar but not identical pro-
gram to MDSi carries out diabetes screening on reserves,
under the auspices of the Aboriginal Diabetes Initiative
[14, 15]). The program provides screening services for
diabetes, diabetes risk, and cardiovascular risk in community
settings.
Prevalence estimates of undiagnosed diabetes and dia-
betesandcardiacrisk factors fromMDSiscreening havebeen
reported elsewhere [9]. The objective of the present study
was to undertake preliminary longitudinal analyses of MDSi
data collected from 2003 to 2009, to identify trends (actual
changes) in health indicators over time for subjects who had
more than one visit during this period.
2.Methods
Two vans transported portable diagnostic equipment and
a team of health professionals (nurse, dietitians, and lab
technician) to the communities to provide diabetes and
cardiovascular screening. The team usually had indigenous
members, and for nonindigenous members signiﬁcant and
ongoing cultural awareness training was provided.
Subjects were volunteers and enrolled in MDSi through
self-referral inresponse tolocalpromotionand outreachcar-
ried out in advance of MDSi visits. Adults as well as children
were enrolled. Trend estimates for children will be reported
elsewhere. Our current analyses include adults only (ages
20–91) with more than one MDSi visit. “Known” diabetes
(i.e., presence of diabetes prior to their ﬁrst MDSi visit) was
conﬁrmed by medications, chart review, or nurse history.
Clinical and anthropometric measurements performed
includedheight and weight (for calculatingbody mass index:
BMI), waist circumference, blood pressure, blood glucose,
lipids (triglycerides and total/fractionated cholesterol), and
hemoglobin A1c (A1c).
Subjects were asked to remove their shoes and any cloth-
ing (such as coats) to be weighed, and waist circumference
was measured using a standard measuring tape at the iliac
crest. Subjects rested for ﬁve minutes prior to a single, seated
blood pressure reading.
Overweight (BMI 25–29.9) and obesity (BMI≥30) were
deﬁned according to criteria from the National Cholesterol
Education Program Adult Treatment Panel III (NCEP ATP
III) [16]. An indigenous-speciﬁc deﬁnition does not exist
for the metabolic syndrome; however, NCEP ATP III criteria
has been shown to be a useful tool for evaluating diabetes
risk in American Indians [17]. We, therefore, used the
NCEP ATP III deﬁnition, for which the presence of three
or more of the following are necessary for a diagnosis: in-
creased waist circumference (>102cm for males; >88cm
for females), elevated triglycerides (≥1.69mmol/L), low
HDL (high density lipoprotein) cholesterol (<1.0mmol/L
in males; <1.3mmol/L in females), diabetes or impaired
fasting glucose (IFG) (≥6.1mmol/L), or hypertension
(≥130/85mmHg) [16].
Subjects had been asked to come to their appointment
fasting though nonfasting subjects were accepted and tested.
Blood was collected via a single ﬁnger puncture with the
Accu-Chek Safe-T-Pro (Roche Diagnostics) lancet. The ﬁrst
blood droplet was discarded using a sterile cotton swab,
and the subsequent blood was collected and immediately
analyzed.International Journal of Family Medicine 3
Table 1: Baseline health indicators. Values are means (±SD) or prevalences (95% CI).
Variables
With known diabetes Without known diabetes Total
(N = 180) (N = 629) (N = 809)
BMI (kg/m2) 33.4 ± 6.2 31.0 ± 6.3 31.5 ± 6.3
% Overweight (25–29.9) 29.5% (17.0–42.0) 32.0% (25.6–38.4) 31.4% (25.7–37.1)
%O b e s e( ≥30) 67.1% (58.6–75.7) 52.8% (47.4–58.2) 55.9% (51.3–60.5)
Waist circumference (cm) 108.6 ± 13.9 101.6 ± 14.7 103.2 ± 14.8
%A b n o r m a l( ≥102 males; ≥88 females) 95.9% (92.9–98.9) 72.8% (68.7–76.9) 78.7% (75.5–81.9)
A1c (%) 7.3 ± 1.6 5.5 ± 0.8 N A
% Poor glucose control (≥7%) 50.0% (41.3–58.7) 1.6% (0.1–3.1) N A
Systolic BP (mmHg) 136.9 ± 19.0 123.8 ± 21.4 126.7 ± 20.3
Diastolic BP (mmHg) 77.4 ± 9.8 75.3 ± 10.4 75.8 ± 10.3
MAP (mmHg) 97.3 ± 12.1 91.5 ± 12.6 92.7 ± 12.4
%H y p e r t e n s i v e( ≥130/80
with diabetes; 140/90 without 69.5% (61.3–77.7) 21.8% (14.9–28.7) 32.3% (26.6–38.0)
diabetes)
Total cholesterol (mM) 4.7 ± 1.1 4.9 ± 1.1 4.8 ± 1.1
% Hypercholesterolemia (≥5.24) 30.8% (18.4–43.2) 34.6% (28.3–40.9) 33.8% (28.1–39.5)
Glucose and lipids were analyzed using the Cholestech
L.D.X (Cholestech Corporation) portable analyzer, and A1c
was analyzed using the Bayer DCA2000+ analyzer (Bayer
Diagnostics). The Cholestech L.D.X utilizes both enzymatic
methodology and solid-phase technology, whereas the Bayer
DCA2000+ is an immunoassay. Performance assessments
of both analyzers were provided by the Canadian External
Quality Assessment Laboratory (CEQAL) with sample sets
covering the clinical range of interest and accuracy target
values assigned by credentialed reference methods. The
base of accuracy for A1c was the Diabetes Control and
Complications Trial (DCCT) Reference Laboratory at the
University of Missouri, whereas CEQAL’s Reference Method
Laboratory was the base of accuracy for lipid measurements.
MDSi ﬁeld staﬀ undertook day-to-day monitoring of the
analytical performance of both instruments via an internal
quality control program with predeﬁned performance limits
and accuracy targets assigned by reference methods.
Adhering to the cutoﬀs set by the Canadian Diabetes
Association (CDA), we deﬁned undiagnosed diabetes as a
fasting plasma glucose (FPG) ≥7.0mmol/L and prediabetes
as a FPG 6.1–6.9mmol/L [5]. Since a single FPG sample is
not adequate to conﬁrm a diagnosis [5], our results only
suggested a provisional diagnosis.
Subjects received a copy of their test results at the time
of service delivery, and the MDSi nurse/dietitians provided
subjects with individualized and culturally sensitive coun-
seling based on their test results. Test results were entered
into MDSi’s proprietary clinical database, and subjects’
prior screening results were available for reference during
counseling. Test results were sent to subjects’ primary care
provideranddiscussedwithlocalhealthcarestaﬀifavailable.
MDSi staﬀ additionally facilitated “lunch and learn”
sessions toshare knowledgewithlocalcare providersonsuch
topics as appropriate screening tests, management strategies,
and lifestyle challenges.
The MDSi project was approved by the Health Research
Ethics Board at the University of Alberta. Consent for
aggregate analysis was obtained from subjects verbally and
in writing; the consentform was read aloud by an MDSiﬁeld
staﬀ member prior to the subject signing.
Individuals with and without known diabetes were an-
alyzed separately. Mean baseline indicators were calculated.
Mean baseline and subsequent indicators were also com-
pared for individuals over time.
Statistical analyses were done with SAS9.1 (SASInstitute
Inc., Cary, NC) and SPSS 17.0 (SPSS Inc., Chicago, IL).
Trend estimates (actual changes) for each indicator were
considered signiﬁcant if P<. 05. Standard deviations and
95% conﬁdence intervals were determined for mean and




A total of 2,954 unique subjects were screened between
November2003and December2009,and a total of4,655vis-
its were completed (including repeat visits). Eight hundred
and nine adults (aged ≥20) had repeat visits, typically at one
year, for a return rate of 27%. Of these 809 individuals, 180
(66% M´ etis, 15% First Nations, and 19% nonindigenous)
were identiﬁed with known diabetes and 629 (66% M´ etis,
17% First Nations, and 17% nonindigenous) without known
diabetes.
Subjects ranged from 20 to 91 years of age (median 45).
We identiﬁed high baseline rates of overweight and obesity
(87%), abnormal waist circumference (79%), hypertension
(32%), and hypercholesterolemia (34%). See Table 1.
Of those subjects with known diabetes, the mean dura-
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Figure 1: Trends for health indicators of returning subjects with known diabetes (N = 180). Values are estimates for the average actual
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Figure 2: Trends for health indicators of returning subjects without known diabetes (N = 629). Values are estimates for the average actual
change per year with 95% CI.
as deﬁned by Canadian Diabetes Association (CDA) criteria
[5]. Of those without diabetes, approximately 2% had A1c
>7.0% indicating undiagnosed diabetes.
Overall trend estimates (actual changes) over time for
adults are shown in Figures 1 and 2.F o rr e t u r n i n gs u b j e c t s
with known diabetes, signiﬁcant improvements (P<. 05)
were observed in BMI, blood pressure, total cholesterol, and
A1c concentrations (Figure 1). Among returning subjects
without known diabetes, improvement was only observed in
bloodpressure (P<. 05),while BMIand waist circumference
increased over time (P<. 01) (Figure 2).
4.Discussion
Loss of culture, language, and traditional food, geographic
isolation, poverty, and status/identity issues are some con-
tributors to the “epidemic” rates of diabetes amongst
Canada’s indigenous population. Sadly, a systematic process
of assimilation through forced attendance at residential
schools resulted in serious sexual, physical and emotional
abuseswithconsequencesthat resonatetothisdayandwhich
have been the subject of an oﬃcial apology by Canada’s
Prime Minister on 11 June 2008 [7, 18].
The MDSi model incorporates principles of partici-
patory research—the ideal is equal participation in
decision making shared between community stakeholders
and researchers [19]—aimed at addressing some of these
social determinants of health via a service delivery frame-
work that is largely community based. While the CDA’s 2003
ClinicalPractice Guidelines(CPGs) recommendedscreening
programs amongst indigenous Canadians be undertaken
within the community setting [20], this recommendation
was unfortunately excluded from the updated CPGs in 2008
[5].
The observed improvements amongst adults with known
diabetes imply that MDSi’s care model may play a role
in supporting subjects to improve their health. However,
since no control group was included, MDSi’s contribution
cannot be quantitated. Additionally, subjects were volunteer
participants, which was likely a source of participant bias.
Secular improvements in diabetes health may be due to a
combination of eﬀects including the availability of clinical
practice guidelines and the federal Aboriginal Diabetes
Initiative (ADI).
Our results for subjects with diabetes parallel trends
reported from a similar project—SLICK (Screening for
Limbs, I-eyes, Cardiovascular and Kidney complications of
diabetes), funded by ADI—involving First Nations people
with diabetes living on reserve in Alberta [21]. SLICK
identiﬁed high baseline rates of overweight and obesity
(92%), abnormal waist circumference (85%), poor andInternational Journal of Family Medicine 5
inadequate glucose control (60% and 35%), hypercholes-
terolemia (44%), and hypertension (62%). However, signiﬁ-
cant improvements in BMI, blood pressure, total cholesterol
and HbA1c concentrations were seen over time for SLICK
subjects who had repeat visits (typically at around one year)
[21].
Longitudinal studies of administrative data in Canada
and the United States have shown similar trends [22, 23].
Dannenbaum et al. showed that the proportion of Eeyou
Istchee First Nations (Quebec) individuals with diabetes
achievingHbA1cconcentrations<7%signiﬁcantlyimproved
from 2002 to 2005 [22].
In the US, the Indian Health Service (IHS) reported
signiﬁcant improvements in HbA1c, cholesterol concentra-
tions, and blood pressure amongst American Indians and
Alaska Natives with diabetes from 1995 to 2001 [23, 24].
Additionally, in 1997, the US Congress established funding
for the IHS Special Diabetes Program for Indians (SDPI),
committing$150millionperyeartowardsdiabetestreatment
and prevention in 399 IHS, Tribal, and Urban Indian health
programs. In SDPI’s ﬁrst eight operational years, reported
clinical outcomes for people with diabetes included signifi-
cant reductions in mean HbA1c (8.9 to 7.9mmol/L) and the
presence of urine protein [25, 26].
For MDSi subjects without diabetes, risk appears to be
increasing, which is disappointing but not surprising, given
the scarcity of the intervention. Occasional lifestyle counsel-
ing would not be expected to make a diﬀerence. Prevention
of diabetes has been shown to be possible in individuals with
impaired glucose tolerance subjected to intense, expensive,
and supervised lifestyle modiﬁcation interventions [27, 28].
Despite MDSi’s eﬀorts to integrate care with local resources,
these services simply do not exist in rural Alberta, where
there is a shortage of generalist and specialist physicians [29]
and where public health and prevention eﬀorts in the area of
chronic disease are only slowly getting underway [1].
A project evaluation for the operational period 2004–
2006 included analysis of the cost of providing an MDSi
service, including startup costs (purchase of diagnostic
equipment, vans, staﬀ training, etc.) and variable ongoing
costs (salaries and beneﬁts, travel, lab supplies, clinical
database development, data storage, etc.) [30]. This analysis
estimated a per client startup cost of $166.76 (Canadian
dollars) and per client ongoing cost of $721.00, for a total
per client cost of $887.76. This compares to a cost analysis
completed in 2004 for the SLICK project, which estimated
a per client ongoing cost of $734.34 (excluding startup
costs) and total per client cost of $917.00 (including startup
costs).
The SLICK analysis further includeda cost minimization
exercise, comparing SLICK service costs with costs for the
same service delivered conventionally via the health care
system. Only those costs that could be directly compared
(materials, personnel, travel, etc.) were assessed. A SLICK
service was estimated to cost $356.55 versus $504.89 for the
same service delivered by the health system [31]. Though no
similar cost minimization analysis has been completed for
MDSi,it is reasonable to assume the cost would approximate
that of a SLICK service ($356.55).
5.Conclusion
In collaboration with the communities and other stakehold-
ers, we have been able to implement a large-scale clinical and
educational diabetes and cardiovascular screening program
in rural and remote northern Alberta. MDSi has had to
mediate not only geographic, but cultural barriers to service
delivery. We have observed signiﬁcant improvements over
time in all measures for subjects with known diabetes, and
improvements in A1c and blood pressure measurements for
clients without known diabetes.
During the summers of 2006, 2007, and 2008, we under-
took a telephone survey, (though using a diﬀerent sample
of our subjects) to examine whether subjects followup with
the recommendation (lifestyle changes, referral for physician
care, etc.) MDSi provided them at screening. Overall 51% of
subjects surveyed reported visiting a physician after MDSi
screening, and (encouragingly) 66% of those MDSi told
they had probable diabetes visited a physician. Most subjects
surveyed reported they felt a need to change their lifestyle
habits to improve their overall health, and the majority of
subjectssurveyedreported some improvement inatleast one
lifestyle factor [32].
The observed improvements from our present study
suggest that MDSi’s model may eﬀectively mediate some
barriers and support subjects in managing their health. Our
emerging evidence supports the rationale for the delivery of
screening, prevention and management at the community-
level.
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